Steven T. Miller

Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.

Najam A. Sharif, S X Xu, Steven T. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 112 citations

Medicine, Medicinal Chemistry, Pharmacology +16

The <i>In Vitro</i> and <i>In Vivo</i> Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent

John M. Yanni, D. J. Stephens, Steven T. Miller et al. · Journal of Ocular Pharmacology and Therapeutics · 1996 · 111 citations

Medicine, Ophthalmology, Pharmacology +16

Comparative Effects of Topical Ocular Anti-Allergy Drugs on Human Conjunctival Mast Cells

John M. Yanni, Steven T. Miller, Daniel A. Gamache et al. · Annals of Allergy Asthma & Immunology · 1997 · 103 citations

Medicine, Immunology, Ophthalmology +16

Interactions of olopatadine and selected antihistamines with model and natural membranes

Howard L. Brockman, Maureen M. Momsen, Joshua R. Knudtson et al. · Ocular Immunology and Inflammation · 2003 · 58 citations

Medicine, Pharmaceutics, Pharmacology +17

Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E2–dependent activation of type II protein kinase A

Troy D. Payner, H.A. Leaver, Brian I. Knapp et al. · Molecular Cancer Therapeutics · 2006 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13